NutraLife BioSciences, Inc. (NLBS)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
+0.0001 (0.00%)
At close: Oct 17, 2024
NutraLife BioSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2016 - 2012 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2016 - 2012 |
| Revenue | 0.63 | 0.63 | 1.26 | 2.13 | 3.71 | 1.79 | Upgrade
|
| Revenue Growth (YoY) | 15.84% | -50.10% | -41.14% | -42.51% | 107.32% | 694.60% | Upgrade
|
| Cost of Revenue | 0.52 | 0.54 | 0.75 | 1.54 | 2.21 | 1.06 | Upgrade
|
| Gross Profit | 0.12 | 0.08 | 0.51 | 0.6 | 1.5 | 0.74 | Upgrade
|
| Selling, General & Admin | 1.85 | 1.87 | 1.98 | 3.38 | 2.34 | 1.84 | Upgrade
|
| Operating Expenses | 2.52 | 4.56 | 2.48 | 3.99 | 3.41 | 21.02 | Upgrade
|
| Operating Income | -2.4 | -4.47 | -1.97 | -3.4 | -1.91 | -20.29 | Upgrade
|
| Interest Expense | -1.86 | -1.85 | -0.92 | -0.01 | -0 | -3.34 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | 0.01 | -0 | -0.6 | -0.15 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -4.23 | -6.32 | -2.89 | -4.01 | -2.06 | -23.63 | Upgrade
|
| Other Unusual Items | 0.24 | 0.49 | - | - | -0.02 | 0 | Upgrade
|
| Pretax Income | -3.99 | -5.83 | -2.89 | -4.01 | -2.07 | -23.63 | Upgrade
|
| Net Income | -3.99 | -5.83 | -2.89 | -4.01 | -2.07 | -23.63 | Upgrade
|
| Net Income to Common | -3.99 | -5.83 | -2.89 | -4.01 | -2.07 | -23.63 | Upgrade
|
| Shares Outstanding (Basic) | 173 | 165 | 146 | 113 | 87 | 72 | Upgrade
|
| Shares Outstanding (Diluted) | 173 | 165 | 146 | 113 | 87 | 72 | Upgrade
|
| Shares Change (YoY) | 8.69% | 12.43% | 29.18% | 29.72% | 21.59% | 113.18% | Upgrade
|
| EPS (Basic) | -0.02 | -0.04 | -0.02 | -0.04 | -0.02 | -0.33 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.04 | -0.02 | -0.04 | -0.02 | -0.33 | Upgrade
|
| Free Cash Flow | -0.67 | -0.49 | -1.28 | -4.4 | -0.82 | -1.19 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.04 | -0.01 | -0.02 | Upgrade
|
| Gross Margin | 18.42% | 13.34% | 40.60% | 28.03% | 40.42% | 41.06% | Upgrade
|
| Operating Margin | -380.49% | -713.77% | -157.12% | -159.14% | -51.36% | -1133.39% | Upgrade
|
| Profit Margin | -631.39% | -929.99% | -230.13% | -187.82% | -55.90% | -1319.94% | Upgrade
|
| Free Cash Flow Margin | -106.44% | -77.78% | -102.27% | -206.17% | -21.99% | -66.43% | Upgrade
|
| EBITDA | -2.18 | -4.36 | -1.85 | -3.27 | -1.84 | -20.21 | Upgrade
|
| EBITDA Margin | - | - | -147.01% | -153.31% | -49.58% | - | Upgrade
|
| D&A For EBITDA | 0.23 | 0.11 | 0.13 | 0.12 | 0.07 | 0.08 | Upgrade
|
| EBIT | -2.4 | -4.47 | -1.97 | -3.4 | -1.91 | -20.29 | Upgrade
|
| EBIT Margin | - | - | -157.12% | -159.14% | -51.36% | - | Upgrade
|
| Advertising Expenses | - | 0.02 | 0.18 | 0.27 | 0.27 | 0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.